Table 2. Symptoms and Extrapulmonary Involvement of Patients With MPP.
Symptom(s) | Survivors N = 187 (%) |
Non-survivors N = 16 (%) |
P value |
---|---|---|---|
Chest pain | 23 (12.3) | 0 | 0.23 |
Dyspnea | 126 (67.3) | 8 (50) | 0.17 |
Cough | 133 (71.1) | 5 (31.2) | 0.003 |
Gastrointestinal | 35 (18.7) | 4 (25) | 0.51 |
Headache | 25 (13.3) | 6 (37.5) | 0.02 |
Weight loss | 6 (3.2) | 0 | 1.00 |
Fever | 100 (53.4) | 10 (62.5) | 0.60 |
Musculoskeletal | 2 (1) | 3 (18.7) | 0.003 |
Exacerbation of obstructive airway disease (OAD) | 39 (20.8) | 1 (6.2) | 0.204 |
Patients given systemic steroids for OAD | 39 (20.8) | 1 (6.2) | 0.204 |
Extrapulmonary involvement of MP | |||
Renal | 81 (43.3) | 15 (93.8) | 0.0001 |
Gastrointestinal | 169 (90.4) | 16 (100) | 0.0001 |
Cardiovascular | 39 (20.8) | 11 (68.8) | 0.0001 |
Hematological | 29 (15.5) | 3 (18.8) | 0.72 |
Musculoskeletal | 106 (56.7) | 16 (100) | 0.0003 |
Pulmonary involvement | 150 (80.2) | 16 (100) | 0.047 |